Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Christopher A. Lino"'
Publikováno v:
Drug Delivery, Vol 25, Iss 1, Pp 1234-1257 (2018)
Gene therapy has long held promise to correct a variety of human diseases and defects. Discovery of the Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR), the mechanism of the CRISPR-based prokaryotic adaptive immune system (CRISPR-a
Externí odkaz:
https://doaj.org/article/b314c626f737436fbb97e72220010ecc
Publikováno v:
Drug Delivery
Drug Delivery, Vol 25, Iss 1, Pp 1234-1257 (2018)
Drug Delivery, Vol 25, Iss 1, Pp 1234-1257 (2018)
Gene therapy has long held promise to correct a variety of human diseases and defects. Discovery of the Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR), the mechanism of the CRISPR-based prokaryotic adaptive immune system (CRISPR-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6c9b148ff7f14452f86e9fee6d7cd0b
https://doi.org/10.1080/10717544.2018.1474964
https://doi.org/10.1080/10717544.2018.1474964
Publikováno v:
Journal of Nanobiotechnology
Background Virus-like particles (VLPs) of the RNA bacteriophage MS2 have many potential applications in biotechnology. MS2 VLPs provide a platform for peptide display and affinity selection (i.e. biopanning). They are also under investigation as vehi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2b55a2fef3da1628dd026f6ad0c2b88
https://doi.org/10.1186/s12951-016-0240-7
https://doi.org/10.1186/s12951-016-0240-7
Autor:
Claire Francesca Melo, Gabriel Garcia, Brian S. Wilkinson, Carlee Erin Ashley, Amber A. McBride, Brandon V. Slaughter, Marissa Anderson Conroy, Christopher A. Lino, Patrick F. Fleig, Eric C. Carnes, Natalie L. Adolphi, Scott M. Reed, Carol S. Ashley, Terry Wu, C. Jeffrey Brinker
Publikováno v:
Frontiers in Bioengineering and Biotechnology. 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f17091493a1ba469cd5390b1910030a6
https://doi.org/10.3389/conf.fbioe.2016.01.03018
https://doi.org/10.3389/conf.fbioe.2016.01.03018
Autor:
Alexander Medford, David S. Peabody, Rhonda C. Kines, Christopher A. Lino, John T. Schiller, Bryce Chackerian, Jerri C. Caldeira
Publikováno v:
Vaccine. 28:4384-4393
The immunogenicity of an antigen can be dramatically increased by displaying it in a dense, multivalent context, such as on the surface of a virus or virus-like particle (VLP). Here we describe a highly versatile VLP platform for peptide display base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fce3d9f49f9df64575468cefbeaf6dbd
https://doi.org/10.1016/j.vaccine.2010.04.049
https://doi.org/10.1016/j.vaccine.2010.04.049
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 12, Iss 5, p e1005614 (2016)
PLoS Pathogens, Vol 12, Iss 5, p e1005614 (2016)
Bacille Calmette–Guérin (BCG) is currently the only approved vaccine against tuberculosis (TB) and is administered in over 150 countries worldwide. Despite its widespread use, the vaccine has a variable protective efficacy of 0–80%, with the low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fabf909d39a6dabf44b0eca9ef92a8c4
https://pubmed.ncbi.nlm.nih.gov/27153120
https://pubmed.ncbi.nlm.nih.gov/27153120
Autor:
Mekensey Buley, Mark B. Carter, C. Jeffrey Brinker, David S. Peabody, David Patrick Padilla, Carlee Erin Ashley, Cheryl L. Willman, Brandy Phillips, Jerri C. Caldeira, Christopher A. Lino, Walker Wharton, Bryce Chackerian, Genevieve K Phillips, Paul N. Durfee, Eric C. Carnes
Virus-like particles (VLPs) of bacteriophage MS2 possess numerous features that make them well-suited for use in targeted delivery of therapeutic and imaging agents. MS2 VLPs can be rapidly produced in large quantities using in vivo or in vitro synth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c606de6fc0849e69b9fca31779fea857
https://europepmc.org/articles/PMC3144304/
https://europepmc.org/articles/PMC3144304/
Publikováno v:
PLoS Pathogens, Vol 12, Iss 5, p e1005614 (2016)
Bacille Calmette-Guérin (BCG) is currently the only approved vaccine against tuberculosis (TB) and is administered in over 150 countries worldwide. Despite its widespread use, the vaccine has a variable protective efficacy of 0-80%, with the lowest
Externí odkaz:
https://doaj.org/article/2269c53bb14043c4b7a5076650015298